Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis

Molecular Aspects of Medicine

Volumn 29, Issue 1-2, 2008, Pages 119-129

  Gatta, Angelo ^a   Bolognesi, Massimo ^a   Merkel, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Carbon monoxide; Liver cirrhosis; Nitric oxide; Portal hypertension; Splanchnic vasodilatation; Splenic circulation

Indexed keywords

ANGIOTENSIN II; CARBON MONOXIDE; CYCLOOXYGENASE 1; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; SUBSTANCE P; THROMBIN; VASOACTIVE AGENT;

ASCITES; CARDIOVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; ESOPHAGUS VARICES; HEART HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERDYNAMIC CIRCULATORY SYNDROME; LIVER CIRRHOSIS; NONHUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; REVIEW; SPLANCHNIC BLOOD FLOW; SPLEEN BLOOD FLOW; VASCULAR RESISTANCE;

ANIMALS; CARBON MONOXIDE; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; NITRIC OXIDE;

EID: 39749129200     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.09.006     Document Type: Review

References (114)

1. Abraldes J.G., Iwakiri Y., Loureiro-Silva M., Haq O., Sessa W.C., and Groszmann R.J. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G980-G987
2. Abraldes J.G., Rodriguez-Vilarrupla A., Graupera M., Zafra C., Garcia-Caldero H., Garcia-Pagan J.C., and Bosch J. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCL4 cirrhotic rats. J. Hepatol. 46 (2007) 1040-1046
3. Almdal T., Schroeder T., and Ranek L. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver disease. Scand. J. Gastroenterol. 24 (1989) 299-303
4. Alwamark A., Bengmark S., Gullstrand P., Joelsson B., Lunderquist A., and Owman T. Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann. Surg. 196 (1982) 518-524
5. Angeli P., Caregaro L., Menon F., Sacerdoti D., De Toni R., Merkel C., and Gatta A. Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: patho-physiological and clinical implications. Hepatology 16 (1992) 1389-1394
6. Angeli P., Volpin R., Gerundi G., Craighero R., Roner P., Merenda R., Amodio P., Sticca A., Caregaro L., Maffei-Faccioli A., and Gatta A. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29 (1999) 1690-1697
7. Angeli P., Fernandez-Varo G., Dalla Libera V., Fasolato S., Galioto A., Arroyo V., Sticca A., Guarda S., Gatta A., and Jimenez W. The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites. Liver Int. 25 (2005) 427-429
8. Atucha N.M., Shah V., Garcia-Cardena G., Sessa W.E., and Groszmann R.J. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology 111 (1996) 1627-1632
9. Barriere E., Tazi K.A., Pessione F., Heller J., Lebrec D., and Moreau R. Evidence of an endothelium-derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosis. Hepatology 32 (2000) 935-941
10. Batkai S., Jarai Z., Wagner J.A., Goparaju S.K., Varga K., Liu J., Wang L., Mirshahi F., Khanolkar A.D., Makriyannis A., Urbaschek R., Garcia Jr. N., Sanyal A.J., and Kunos G. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med. 7 (2001) 827-832
11. Battista S., Bar F., Mengozzi G., Zanon E., Grosso M., and Molino G. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J. Hepatol. 26 (1997) 75-80
12. Benoit J.N., and Granger D.N. Splanchnic hemodynamics in chronic portal venous hypertension. Semin. Liver Dis. 6 (1986) 287-291
13. Benoit J.N., Womack W.A., Hernandez L., and Granger D.N. "Forward" and "backward" flow mechanisms of portal hypertension. Relative contributions in a rat model of portal vein stenosis. Gastroenterology 89 (1985) 1092-1096
14. Bernardi M., and Trevisani F. Systemic and regional hemodynamics in pre-ascitic cirrhosis. J. Hepatol. 27 (1997) 588-591
15. Bernardi M., Di Marco C., Trevisani F., De Collibus C., Fornalè L., Baraldini M., Androne P., Cursaro C., Zaca F., and Ligabue A. The hemodynamic status of pre-ascitic cirrhosis: an evaluation under steady state condition and after postural change. Hepatology 16 (1992) 341-346
16. Bhathal P.S., and Groszmann H.J. Reduction of the increased portal vascular resistance of isolated perfused cirrhotic rat liver by vasodilators. J. Hepatol. 1 (1985) 325-337
17. Blendis L.M. Portal hypertension. In: Lautt W.W. (Ed). Hepatic Circulation in Health and Disease (1981), Raven Press, NY 329-350
18. Bolognesi M., Merkel C., Sacerdoti D., Nava V., and Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Dig. Liver Dis. 34 (2002) 144-150
19. Bolognesi M., Sacerdoti D., Di Pascoli M., Angeli P., Quarta S., Sticca A., Pontisso P., Merkel C., and Gatta A. Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites. Gut 54 (2005) 1630-1636
20. Bolognesi M., Sacerdoti D., Piva A., Di Pascoli M., Zampieri F., Quarta S., Motterlini R., Angeli P., Merkel C., and Gatta A. Carbon monoxide-activation of large-conductance calcium activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats. J. Pharm. Exp. Ther. 321 (2007) 187-194
21. Bosch J., Arroyo V., Betriu A., Mas A., Rivera F., Navaro-Lopez F., and Rodes J. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 78 (1980) 92-99
22. Bosch J., Pizcueta P., Feu F., Fernandez H., and Garcia-Pagan C.G. Pathophysiology of portal hypertension. Gastroenterol. Clin. N. Am. 21 (1992) 1-14
23. Bradley S.E., Ingrlfinger F.J., and Bradley G.P. Hepatic circulation in cirrhosis of the liver. Circulation 5 (1952) 419-429
24. Brandt C.T., Rothbarth L.J., Kumpe D., Karrer F.M., and Lilly J.R. Splenic embolization in children: long-term efficacy. J. Pediatr. Surg. 24 (1989) 642-644
25. Bruix J., Bosch J., Kravetz D., Mastai R., and Rodes J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology 88 (1985) 430-435
26. Cahill P.A., Redmond E.M., Hodges R., Zhang S., and Sitzmann J.V. Increased endothelial nitric oxide synthase activity in the hyperemic vessel of portal hypertensive rates. J. Hepatol. 25 (1996) 370-378
27. Carrion J.A., Navasa M., Bosch J., Bruguera M., Gilabert R., and Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver. Transpl. 12 (2006) 1791-1798
28. Chen Y.C., Gines P., Yang J., Summer S.N., Falk S., Russell N.S., and Schrier R.W. Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats. Hepatology 39 (2004) 1075-1087
29. Clemens M.G. Does altered regulation of ecNOS in sinusoidal endothelial cells determine increased intrahepatic resistance leading to portal hypertension?. Hepatology 27 (1998) 1745-1747
30. Dam M., Burra P., Tedeschi U., Cagnin A., Chierichetti F., Ermani M., Ferlin G., Naccarato R., and Pizzolato G. Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. J. Hepatol. 29 (1998) 78-84
31. Dillon J.F., Plevris J.N., Wong F.C., Chang K.H., Lo N.T., Miller J.D., Bouchier I.A., and Hayes P.C. Middle cerebral artery blood flow velocity in patients with cirrhosis. Eur. J. Gastroenterol. Hepatol. 7 (1995) 1087-1091
32. Domenicali M., Ros J., Fernandez-Varo G., Cejudo-Martin P., Crespo M., Morales-Ruiz M., Briones A.M., Campistol J.M., Arroyo V., Vila E., Rodes J., and Jimenez W. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut 54 (2005) 522-527
33. Epstein M., Berk D.P., Hollenberg N.K., Adams D.F., Chalmers T.C., Abrams H.L., and Merrill J.P. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am. J. Med. 49 (1970) 175-185
34. Fernandez M., and Bonkovsky H.L. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 29 (1999) 1672-1679
35. Fernandez M., Garcia-Pagan J.C., Casadevall M., Mourelle M.I., Pique J.M., Bosch J., and Rodes J. Acute and chronic blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis. Gastroenterology 110 (1996) 1529-1535
36. Fernandez M., Lambrecht R.W., and Bonkovsky H.L. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. J. Hepatol. 34 (2001) 812-817
37. Fernandez-Rodriguez C.M., Prada I.R., Prieto J., Mntuenga L.M., Elssasser T., Quiroga J., Moreiras M., Andrade A., and Cuttitta F. Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation. J. Hepatol. 98 (1998) 250-256
38. Garcia-Cardena G., Fan R., Stern D.F., Liu J., and Sessa W.C. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271 (1996) 27237-27240
39. Garcia-Pagan J.C., Salmeron J.M., Feu F., Luca A., Gines P., Pizcueta P., Claria J., Piera C., Arroyo V., Bosch J., and Rodes J. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology 19 (1994) 1095-1099
40. Gatta A., Merkel C., Grassetto M., Milani L., Zuin R., and Ruol A. Enhanced renal sympathetic tone in liver cirrhosis: evaluation by intrarenal administration of dihydroergocristine. Nephron 30 (1982) 364-367
41. Gatta A., Sacerdoti D., Merkel C., Milani L., Battaglia G., and Zuin R. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension. Am. Heart J. 108 (1984) 1167-1172
42. Gatta A., Sacerdoti D., Bolognesi M., and Merkel C. Portal hypertension: state of the art. Ital. J. Gastroenterol. Hepatol. 31 (1999) 326-445
43. Gitlin N., Grahame G.R., Kreel L., Williams H.S., and Sherlock S. Splenic blood flow and resistance in patients with cirrhosis before and after portacaval anastomoses. Gastroenterology 59 (1970) 208-213
44. Goda N., Suzuki K., Naito M., Takeoka S., Tsuchida E., Ishimura Y., Tamani T., and Suematsu M. Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J. Clin. Invest. 101 (1998) 604-612
45. Gracia-Sancho J., Lavina B., Rodriguez-Vilarrupla A., Garcia-Caldero H., Bosch J., and Garcia-Pagan J.C. Enhanced vasoconstrictor prostanoid production by sinusoidal endotehlial cells increases portal perfusion pressure in cirrhotic rat livers. J. Hepatol. 27 (2007) 220-227
46. Graupera M., Garcia-Pagan J.C., Abraldes J.G., Peralta C., Bragulat M., Corominola H., Bosch J., and Rodes J. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 37 (2003) 172-181
47. Graupera M., March S., Engel P., Rodes J., Bosch J., and Garcia-Pagan J.C. Sinusoidal endothelial COX-1 prostaoids modulate the hepatic vascular tone of cirrhotic rat livers. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G763-G770
48. Guevara M., Bru C., Gines P., Fernandez-Esparrach G., Sort P., Bataller R., Jimenez W., Arroyo V., and Rodes J. Increased cerebrovascular resistance in cirrhotic patients with ascites. Hepatology 28 (1998) 39-44
49. Guevara M., Gines P., Jimenez W., Sort P., Fernandez-Esparrach G., Escorsell A., Bataller R., Bosch J., Arroyo V., Rivera F., and Rodes J. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstriction systems. Gastroenterology 114 (1998) 336-343
50. Gupta T.K., Toruner M., Chung M.K., and Groszmann R.J. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28 (1998) 926-931
51. Gusberg R.J., Peterec S.M., Sumpio B.E., and Meier G.H. Splenomegaly and variceal bleeding - hemodynamic basis and treatment implications. Hepatogastroenterology 41 (1994) 573-577
52. Hadengue A., Gadano A., Moreau R., Giostra E., Durand F., Valla D., Erlinger S., and Lebrec D. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J. Hepatol. 29 (1998) 565-570
53. Hamilton G., Phing R.C., Hutton R.A., Dandona P., and Hobbs K.E. The relationship between prostacyclin activity and pressure in the portal vein. Hepatology 2 (1982) 236-242
54. Heller J., Schepke M., Grhnen N., Molderings G.J., Muller A., Erhard J., Spengler U., and Sauerbruch T. Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis. Gastroenterology 116 (1999) 387-393
55. Hernandez-Guerra M., Gracia-Pagan J.C., Turnes J., Bellot P., Deulofeu R., Abraldes J.G., and Bosch J. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension. Hepatology 43 (2006) 485-491
56. Hori N., Okanoue T., Sawa Y., and Kashima K. Role of calcitonin gene-related peptide in the vascular system on the development of the hyperdynamic circulation in conscious cirrhotic rats. J. Hepatol. 26 (1997) 1111-1119
57. Hou M.C., Cahill P.A., Zhang S., Wang Y.N., Hendrickson R.J., Redmond E.M., and Sitzmann J.V. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation. Hepatology 27 (1998) 20-27
58. Iwakiri Y., and Groszmann R.J. The hyperdynamic circulation of chronic liver diseases: from the patients to the molecule. Hepatology 46 (2006) S121-S131
59. Jimenez W., and Rodes J. Impaired responsiveness to endogenous vasoconstrictors and endothelium derived vasoactive factors in cirrhosis. Gastroenterology 107 (1994) 1201-1203
60. Kenawi M.M., el-Ghamrawi K.A., Mohammad A.A., Kenawi A., and el-Sadek A.Z. Splenic irradiation for the treatment of hypersplenism from congestive splenomegaly. Br. J. Surg. 84 (1997) 860-861
61. Leivas A., Jimenez W., Bruix J., Bosch J., Arroyo V., Rivera F., and Rodes J. Gene expression of endothelin-1 and ETA and ETB receptors in human cirrhosis: relationship with hepatic hemodynamics. J. Vasc. Res. 35 (1998) 186-193
62. Lieberman F.L., and Reynolds T. Plasma volume in cirrhosis of the liver: its relation to portal hypertension, ascites and renal failure. J. Clin. Invest. 46 (1967) 1297-1308
63. Loureiro-Silva M.R., Cadelina G.W., and Groszmann R.J. Deficit in nitric oxide production in cirrhosis rats livers is located in the sinusoidal and postsinusoidal areas. Am. J. Physiol. Gastrointerst. Liver Physiol. 284 (2003) G567-G574
64. Loureiro-Silva M.R., Cadelina G.W., Iwakiri Y., and Groszmann R.J. A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and metoxamine in cirrhotic rats. J. Hepatol. 39 (2003) 940-946
65. Loureiro-Silva M.R., Iwakiri Y., Abraldes J.G., Haq O., and Groszmann R.J. Increased phosphodieserase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers. J. Hepatol. 44 (2006) 886-893
66. Mallat A., Fouassier L., Preaux A.M., Serradeil-LeGal C., Raufaste D., Rosenbaum J., Dhumeaux D., Jouneaux C., Mavier P., and Lotersztajn S. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathways. J. Clin. Invest. 96 (1995) 42-49
67. Maroto A., Gines P., Arroyo V., Gines A., Salo J., Claria J., Jimenez W., Bru C., Rivera F., and Rodes J. Brachial and femoral blood flow in cirrhosis. Hepatology 17 (1993) 788-793
68. 4 cirrhosis. Hepatology 44 (2006) 44-52
69. Merkel C., Gatta A., Milani L., Amodio P., and Zuin R. Intrarenal blood flow, circulation time, and cortical vascular volume in patients with cirrhosis. Scand. J. Gastroenterol. 16 (1981) 775-780
70. Merkel C., Gatta A., Arnaboldi L., and Zuin R. Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clin. Physiol. 5 (1985) 531-539
71. Merkel C., Sacerdoti D., Bolognesi M., Enzo E., Marin R., Bombonato G., Angeli P., and Gatta A. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology 26 (1997) 34-39
72. Moezi L., Gaskari S.A., Liu H., Baik S.K., Dehpour A.R., and Lee S.S. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptors. Br. J. Pharmacol. 149 (2006) 898-908
73. Morales-Ruiz M., Jimenez W., Perez-Sala D., Ros J., Leivas A., Lamas S., Rivera F., and Arroyo V. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 24 (1996) 1481-1886
74. Moreno A.H., Burchell A.R., Rousselot L.M., Panke W.F., Slafsky F., and Bulke J.H. Portal blood flow in cirrhosis of the liver. J. Clin. Invest. 46 (1967) 436-445
75. Motterlini R., Gonzales A., Foresti R., Clark J.E., Green C.J., and Winslow R.M. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ. Res. 83 (1998) 568-577
76. Murata K., Shiraki K., Takase K., Nakano T., and Tameda Y. Long term follow-up for patients with liver cirrhosis after partial splenic embolization. Hepatogastroenterology 43 (1996) 1212-1217
77. Nagula S., Jain D., Groszmann R.J., and Garcia-Tsao G. Histological-hemodynamic correlation in cirrhosis a histological classification of the severità of cirrhosis. J. Hepatol. 44 (2006) 111-117
78. Newby D.E., and Hayes P.C. Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but "splanchnic steal". Q. J. Med. 95 (2002) 827-830
79. Niederberger M., Martin P.Y., Gines P., Morris K., Tsai P., Xu D.L., McMurtry I., and Schier R.W. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 109 (1995) 1624-1630
80. Okuda K., Kono K., Ohnishi K., Kimura K., Omata M., Koen H., Nakajima Y., Musha H., Hirashima T., Takashi M., and Takayasu K. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86 (1984) 600-610
81. Okumura H., Aramaki T., Katsuta Y., Satomura K., Akaike M., Sekiyama T., Terada H., Ohsuga M., Komeichi H., and Tsutsi H. Reduction in hepatic vein pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites. Am. J. Gastroenterol. 86 (1991) 46-52
82. Perez-Ruiz M., Ros J., Morales-Ruiz M., Navasa M., Colmenero J., Ruiz del Arbol L., Cejudo P., Claria J., Rivera F., Arroyo V., Rodes J., and Jimenez W. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide. Hepatology 29 (1999) 1057-1063
83. Pinzani M., Milani S., De Franco R., Grappone C., Caligiuri A., Gentilini A., Tosti-Guerra C., Maggi M., Failli P., Ruocco C., and Gentilini P. Endothelin 1 overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110 (1996) 534-538
84. Poo J.L., Braillon A., Hadengue A., Gaudin C., and Lebrec D. Hemodynamic effects of terbutaline, a ß2-adrenoreceptor agonist, in conscious rats with secondary biliary cirrhosis. Hepatology 15 (1992) 459-463
85. Poo J.L., Jimenez W., Munoz R.M., Bosch-Marcè M., Bordas N., Morales-Ruiz M., Perez M., Deulofeu R., Sole M., Arroyo V., and Rodes J. Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects. Gastroenterology 116 (1999) 161-167
86. Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 25 (1997) 2-5
87. Rockey D.C., and Chung J.J. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 114 (1998) 344-351
88. Rockey D.C., Fouassier L., Chung J.J., Carayon A., Vallee P., Rey C., and Housset C. Cellular localization of endothelin-1 and increased production in liver injury in the rats: potential for autocrine and paracrine effects on stellate cells. Hepatology 27 (1998) 472-480
89. Ros J., Claria J., To-Figueras J., Planaguma A., Cejudo-Martin P., Fernandez-Varo G., Martin-Ruiz R., Arroyo V., Rivera F., Rodes J., and Jimenez W. Endogenous cannabinoids : a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 122 (2002) 85-93
90. Sacerdoti D., Merlo A., Merkel A., Zuin R., and Gatta A. Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2. J. Hepatol. 2 (1986) 253-261
91. Sacerdoti D., Bolognesi M., Merkel C., Angeli P., and Gatta A. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology 17 (1993) 219-224
92. Sacerdoti D., Abraham N.G., Oyekan A.O., Yang L., Gatta A., and McGiff J.C. Role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats. J. Pharmacol. Exp. Ther. 308 (2004) 636-643
93. Salerno F., Gerbes A., Gines P., Wong F., and Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56 (2007) 1310-1318
94. Sarela A.I., Mihaimeed F.M.A.M., Batten J.J., Davidson B.R., and Mathie R.T. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut 44 (1999) 749-753
95. Schneider A.W., Kalk J.F., and Klein C.P. Effect of Losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 29 (1999) 334-339
96. Schrier R.W., Arroyo V., Bernardi M., Epstein M., Henrikson J.H., and Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8 (1988) 1151-1157
97. Shah V., Haddad F.G., Garcia-Gardena G., Frangos J.A., Mennone A., Groszmann R.J., and Sessa W.C. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J. Clin. Invest. 100 (1997) 2923-2930
98. Sherwin R., Joshi P., Hendler R., Felig P., and Conn H.O. Hyperglucagonemia in Lannec's cirrhosis. The role of portal-systemic shunt. N. Eng. J. Med. 290 (1974) 239-242
99. Sogni P., Moreau R., Gadano A., and Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J. Hepatol. 23 (1995) 218-224
100. Steib C.J., Gerbes A.L., Bystron M., op den Winkel M., Hartl J., Roggel F., Prufer T., Goke B., and Bilzer M. Kupffer cell activation in nomrla and fibrotic livers increases portal pressure via thromboxane A2. J. Hepatol. 47 (2007) 228-238
101. Suematsu M., Kashiwagi S., Sano T., Goda N., Shinoda Y., and Ishimura Y. Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem. Biophys. Res. Comm. 205 (1994) 1333-1337
102. Suematsu M., Goda N., Sano T., Kashiwagi S., Egawa T., Shinoda Y., and Ishimura Y. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J. Clin. Invest. 96 (1995) 2431-2437
103. Sumanoski L.T., Battegay E., Stumm M., Van der Kooij M., and Sieber C.C. Increased angiogenesis in portal hypertensive rats: role of nitric oxide. Hepatology 29 (1999) 1044-1049
104. Takagi K., Ashida H., and Utsunomiya J. The effect of splenomegaly on splanchnic hemodynamics in nonalcoholic cirrhosis after distal splenorenal shunt and splenopancreatic disconnection. Hepatology 20 (1994) 342-348
105. Tisdale W.A., Klatskin G., and Glenn W.W. Portal hypertension and bleeding esophageal varices: their occurrence in the absence of both intrahepatic and extrahepatic obstruction of the portal vein. N. Eng. J. Med. 261 (1959) 209-218
106. Uriz J., Gines P., Cardenas A., Sort P., Jimenez W., Salmeron J.M., Bataller R., Mas A., Navasa M., Arroyo V., and Rodes J. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J. Hepatol. 33 (2000) 43-48
107. Vallance P., and Moncada S. Hyperdynamic circulation in cirrhosis. A role for nitric oxide. Lancet i (1991) 776-778
108. Vorobioff J., Bredfeld J., and Groszmann R.J. Hyperdynamic circulation in a portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am. J. Physiol. 224 (1983) G52-G60
109. Whittle B.J.R., and Moncada S. Nitric oxide: the elusive mediator of the hyperdynamic circulation of cirrhosis?. Hepatology 16 (1992) 1089-1092
110. Wiest R., Das S., Cadelina G., Garcia-Tsao G., Milstien S., and Groszmann R.J. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J. Clin. Invest. 104 (1999) 1223-1233
111. Williams R., Condon R.E., Williams H.S., Blendis L.M., and Kreel K. Splenic blood flow in cirrhosis and portal hypertension. Clin. Sci. 34 (1968) 441-452
112. Witte C.L., Witte M.H., Bair G., Mobley W.P., and Morton D. Experimental study of hyperdynamic vs. stagnant mesenteric blood flow in portal hypertension. Ann. Surg. 179 (1974) 304-310
113. Zafra C., Abraldes J.C., Turnes J., Berzigotti A., Fernandez M., Garcia-Pagan J.C., Rodes J., and Bosch J. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology 126 (2004) 749-755
114. Zimmon D.S., and Kessler R.E. The portal pressure-blood volume relationship in cirrhosis. Gut 15 (1974) 99-101